摘要
Background Berberine, a non-prescription medicine clinically applied for diarrhoea and gastroenteritis. Recent studies have demonstrated that it possesses anti-tumour properties in colorectal cancer, but the exact molecular mechanism remains obscure. @@@ Objectives To elucidate the underly molecular mechanisms of berberine in colorectal cancer from a perspective of epigenetics, and tried to explore the role of lincROR-Wnt/beta-catenin molecular axis in the berberine induced the anti-tumour activity in colorectal cancer. @@@ Methods The effects of berberine on cell growth, cell cycle and apoptosis were examined in CRC cells. The in vivo effect of berberine on tumour growth was investigated using a xenograft mice model. Moreover, lincROR and Wnt/beta-catenin signalling were detected by luciferase activity, qRT-PCR and western blotting assays. @@@ Key findings Berberine suppressed cell growth in vitro via inducing cell cycle arrest and apoptosis in CRC cell, and inhibited tumourigenesis in vivo. LincROR was significantly down-regulated by berberine, inducing the inactivation of the canonical Wnt/beta-catenin signalling, meanwhile, the overexpression of lincROR partially reversed the suppressive effects on tumour growth and Wnt/beta-catenin signalling induced by berberine. @@@ Conclusions Berberine inhibits tumour growth partially via regulating the lincROR-Wnt/beta-catenin regulatory axis, which provides a strategy for the design of anti-tumour drugs for CRC patients after our advanced validation.
学科与关键词
- Berberrubine is a novel and selective IMPDH2 inhibitor that impairs the growth of colorectal cancerHe, Xiangli; Cui, Jiayan; Ma, Hui; Abuduaini, Naijipu; Huang, Ying; Tang, Lu; Wang, Wanyan; Zhang, Yuanyuan; Wang, Yang; Lu, Weiqiang*; Feng, Bo*; Huang, Jin*Biochemical Pharmacology, 2023, 218: 115868.
- Icariside II suppressed tumorigenesis by epigenetically regulating the circβ-catenin-Wnt/β-catenin axis in colorectal cancerShi, Chuan-Jian; Li, Shi-Ying; Shen, Chun-Hui; Pan, Fei-Fei; Deng, Li-Qiang; Fu, Wei-Ming*; Wang, Ji-Yong*; Zhang, Jin-Fang*Bioorganic Chemistry, 2022, 124: 105800.被引 2
- Dimeric oxyberberine CT4-1 targets LINC02331 to induce cytotoxicity and inhibit chemoresistance via suppressing Wnt/β-catenin signaling in hepatocellular carcinomaLin, Xian; Chen, Jian; Li, Xin; Chen, Dong; Luo, Kaixuan; Deng, Yongxing; Yang, Dinghua*; Huang, Zunnan*; Tao, Cheng*Archives of Toxicology, 2023, 97(6): 1627-1647.被引 2
